Drug Type Autologous CAR-T |
Synonyms |
Target |
Action inhibitors |
Mechanism CD123 inhibitors(Interleukin-3 receptor subunit alpha inhibitors), CD33 inhibitors(Myeloid cell surface antigen CD33 inhibitors), CLL-1 inhibitors(C-Type lectin domain family 12 member A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Preclinical | United Kingdom | 03 Aug 2023 | |
Acute Myeloid Leukemia | Preclinical | United Kingdom | 03 Aug 2023 |